Press release
Biliary Tract Cancer Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharma, Eisai
DelveInsight's "Biliary Tract Cancer Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Biliary Tract Cancer, historical and forecasted epidemiology as well as the Biliary Tract Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Biliary Tract Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Biliary Tract Cancer Market Forecast [https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Biliary Tract Cancer Market Report:
*
The Biliary Tract Cancer market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In December 2024, Jazz Pharmaceuticals announced that the U.S. FDA has granted accelerated approval for Ziihera Registered (zanidatamab-hrii) 50mg/mL for intravenous administration. This approval is for the treatment of adults with previously treated, unresectable, or metastatic HER2-positive biliary tract cancer (BTC), confirmed by an FDA-approved test.
*
In November 2024, CTX-009 is a bispecific antibody that targets both Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A), two pathways crucial for angiogenesis and tumor vascularization. Preclinical and early clinical data suggest that inhibiting both pathways offers strong anti-tumor effects across various solid tumors, including colorectal, gastric, cholangiocarcinoma, pancreatic, and non-small cell lung cancer. Partial responses have been observed in heavily pre-treated cancer patients who were resistant to approved anti-VEGF therapies. The COMPANION-002 trial, a Phase 2/3 study, is evaluating the combination of CTX-009 and paclitaxel versus paclitaxel alone in patients with previously treated, advanced metastatic or recurrent biliary tract cancers (BTC). Clinical trial information: NCT05506943.
*
In August 2024, Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company focused on oncology and developing proprietary antibody-based therapeutics for various diseases, today announced the completion of patient enrollment in its COMPANION-002 trial. The trial, a randomized Phase 2/3 study, involves 150 patients and evaluates CTX-009 in individuals with biliary tract cancer (BTC).
*
In June 2024, Bold Therapeutics, a global leader in the development of innovative metallotherapeutics, announced positive Phase 2 safety and efficacy results for its lead asset, BOLD-100, in the treatment of advanced metastatic biliary tract cancer (BTC) and gastric cancer (GC) at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL.
*
Chemotherapy regimens currently dominate the market. However, several promising therapies in development, such as CX-4945 and CTX-009, are anticipated to significantly impact the Biliary Tract Cancer treatment landscape during the forecast period (2024-2034).
*
In 2023, the United States held the largest share of the Biliary Tract Cancer market in the 7MM, representing nearly 48% of the market, compared to the EU4, the UK, and Japan.
*
In 2023, the United States represented approximately 30% of the total incident cases of Biliary Tract Cancer in the 7MM, accounting for the highest number of cases within this region.
*
In the United States, the majority of Biliary Tract Cancer cases occur in individuals aged 70-79 years, accounting for approximately 30% of all age-specific cases.
*
In the United States, TP53 mutations were the most prevalent among mutation-specific cases of Biliary Tract Cancer in 2023, followed by KRAS mutations.
*
Key Biliary Tract Cancer Companies: Senhwa Biosciences, Incyte, Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Eisai, Zymeworks, BeiGene, Xencor, Inc., Bristol-Myers Squibb, Leap Therapeutics, Inc., Compass Therapeutics, Boehringer Ingelheim, ZielBio, Inc., GeneQuantum Healthcare (Suzhou) Co., Ltd., BioNTech SE, SOTIO Biotech, Carisma Therapeutics Inc, Rain Oncology Inc, Avacta Life Sciences Ltd, DualityBio Inc., and others
*
Key Biliary Tract Cancer Therapies: PEMAZYRE (pemigatinib), Silmitasertib (CX-4945), Keytruda (pembrolizumab), Imfinzi (durvalumab), Futibatinib (TAS-120), Melphalan, E7090 (tasurgratinib), TT-00420, ARQ 087 (Derazantinib), Lenvima (lenvatinib), Zanidatamab, XmAb20717, Nivolumab + DKN-01, CTX-009, MEDI5752, Brigimadlin, ZB131, GQ1001, BNT141, SO-C101, CT-0508, RAIN-32, AVA6000, DB-1303, and others
*
The Biliary Tract Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Biliary Tract Cancer pipeline products will significantly revolutionize the Biliary Tract Cancer market dynamics.
Biliary Tract Cancer Overview
Biliary Tract Cancer (BTC) is a rare and aggressive cancer that originates in the bile ducts, which are responsible for carrying bile from the liver to the small intestine. It includes cancers of the bile ducts inside and outside the liver, as well as the gallbladder. Symptoms can be vague and may include jaundice, abdominal pain, and weight loss, often leading to delayed diagnosis. BTC is typically diagnosed in later stages, making treatment more challenging. Treatment options may include surgery, chemotherapy, and targeted therapies, depending on the cancer's location and stage.
Get a Free sample for the Biliary Tract Cancer Market Report:
https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market [https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Biliary Tract Cancer Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Biliary Tract Cancer Epidemiology Segmentation:
The Biliary Tract Cancer market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Biliary Tract Cancer
*
Prevalent Cases of Biliary Tract Cancer by severity
*
Gender-specific Prevalence of Biliary Tract Cancer
*
Diagnosed Cases of Episodic and Chronic Biliary Tract Cancer
Download the report to understand which factors are driving Biliary Tract Cancer epidemiology trends @ Biliary Tract Cancer Epidemiology Forecast [https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Biliary Tract Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Biliary Tract Cancer market or expected to get launched during the study period. The analysis covers Biliary Tract Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Biliary Tract Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Biliary Tract Cancer Therapies and Key Companies
*
PEMAZYRE (pemigatinib): Incyte
*
Silmitasertib (CX-4945): Senhwa Biosciences
*
Keytruda (pembrolizumab): Merck Sharp & Dohme
*
Imfinzi (durvalumab): AstraZeneca
*
Futibatinib (TAS-120): Taiho Oncology
*
Melphalan: Delcath Systems
*
E7090 (tasurgratinib): Eisai
*
TT-00420: TransThera Sciences (Nanjing)
*
ARQ 087 (Derazantinib): Basilea Pharmaceutica
*
Lenvima (lenvatinib): Eisai and Merck & Co
*
Zanidatamab: Zymeworks and BeiGene
*
XmAb20717: Xencor, Inc.
*
Nivolumab + DKN-01: Bristol-Myers Squibb/Leap Therapeutics, Inc.
*
CTX-009: Compass Therapeutics
*
MEDI5752: AstraZeneca
*
Brigimadlin: Boehringer Ingelheim
*
ZB131: ZielBio, Inc.
*
GQ1001: GeneQuantum Healthcare (Suzhou) Co., Ltd.
*
BNT141: BioNTech SE
*
SO-C101: SOTIO Biotech
*
CT-0508: Carisma Therapeutics Inc
*
RAIN-32: Rain Oncology Inc
*
AVA6000: Avacta Life Sciences Ltd
*
DB-1303: DualityBio Inc.
Discover more about therapies set to grab major Biliary Tract Cancer market share @ Biliary Tract Cancer Treatment Market [https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Biliary Tract Cancer Market Strengths
*
The therapeutic landscape in BTCs has expanded considerably in recent years. Combined therapy with chemotherapy, immunotherapy, and modulation of immune checkpoints-mediated signaling pathways are promising strategies.
Biliary Tract Cancer Market Opportunities
*
Increasing cognizance about different mutations, pathways, and other regimens has changed the focus on curable treatment options with emerging candidates that will lead the growth of the global market.
Scope of the Biliary Tract Cancer Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Biliary Tract Cancer Companies: Senhwa Biosciences, Incyte, Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Eisai, Zymeworks, BeiGene, Xencor, Inc., Bristol-Myers Squibb, Leap Therapeutics, Inc., Compass Therapeutics, Boehringer Ingelheim, ZielBio, Inc., GeneQuantum Healthcare (Suzhou) Co., Ltd., BioNTech SE, SOTIO Biotech, Carisma Therapeutics Inc, Rain Oncology Inc, Avacta Life Sciences Ltd, DualityBio Inc., and others
*
Key Biliary Tract Cancer Therapies: PEMAZYRE (pemigatinib), Silmitasertib (CX-4945), Keytruda (pembrolizumab), Imfinzi (durvalumab), Futibatinib (TAS-120), Melphalan, E7090 (tasurgratinib), TT-00420, ARQ 087 (Derazantinib), Lenvima (lenvatinib), Zanidatamab, XmAb20717, Nivolumab + DKN-01, CTX-009, MEDI5752, Brigimadlin, ZB131, GQ1001, BNT141, SO-C101, CT-0508, RAIN-32, AVA6000, DB-1303, and others
*
Biliary Tract Cancer Therapeutic Assessment: Biliary Tract Cancer current marketed and Biliary Tract Cancer emerging therapies
*
Biliary Tract Cancer Market Dynamics: Biliary Tract Cancer market drivers and Biliary Tract Cancer market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Biliary Tract Cancer Unmet Needs, KOL's views, Analyst's views, Biliary Tract Cancer Market Access and Reimbursement
To know more about Biliary Tract Cancer companies working in the treatment market, visit @ Biliary Tract Cancer Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Biliary Tract Cancer Market Report Introduction
2. Executive Summary for Biliary Tract Cancer
3. SWOT analysis of Biliary Tract Cancer
4. Biliary Tract Cancer Patient Share (%) Overview at a Glance
5. Biliary Tract Cancer Market Overview at a Glance
6. Biliary Tract Cancer Disease Background and Overview
7. Biliary Tract Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Biliary Tract Cancer
9. Biliary Tract Cancer Current Treatment and Medical Practices
10. Biliary Tract Cancer Unmet Needs
11. Biliary Tract Cancer Emerging Therapies
12. Biliary Tract Cancer Market Outlook
13. Country-Wise Biliary Tract Cancer Market Analysis (2020-2034)
14. Biliary Tract Cancer Market Access and Reimbursement of Therapies
15. Biliary Tract Cancer Market Drivers
16. Biliary Tract Cancer Market Barriers
17. Biliary Tract Cancer Appendix
18. Biliary Tract Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=biliary-tract-cancer-market-poised-for-significant-growth-from-2024-to-2034-reports-delveinsight-astrazeneca-taiho-oncology-delcath-systems-transthera-sciences-nanjing-basilea-pharma-eisai]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biliary Tract Cancer Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharma, Eisai here
News-ID: 3840010 • Views: …
More Releases from ABNewswire
Tampa Bay Remodeling Trends 2025: What Homeowners Are Choosing for Kitchen, Bath …
Tampa Bay's home remodeling trends in 2025 reflect a growing demand for smart kitchens, spa-style bathrooms, energy-efficient upgrades, and multi-generational living solutions. Based on local projects across South Tampa, Clearwater, and Wesley Chapel, this analysis highlights the top renovation features Tampa homeowners are prioritizing, with insights from licensed contractor Dan Blizer of Craftline Remodeling.
Industry Analysis Reveals Shift Toward Sustainable Materials, Smart Home Integration, and Multi-Generational Design Solutions
Tampa Bay's home remodeling…
Durable, Precise, Powerful: Meet HUDEF's Apex Pro2 Pickleball Paddle
Many pickleball players face issues with paddles that lose shape or fail to provide consistent control after repeated use. Traditional foam and EPP cores, while lightweight, often deform, negatively impacting accuracy and performance. The HUDEF Apex Pro2 Pickleball Paddle addresses these problems with its innovative Supercritical Foaming Polypropylene Honeycomb Core, ensuring durability and improved performance during gameplay.
New York - Sep 10, 2025 - Many pickleball players struggle with paddles that…
Morristown, NJ Homeowners Trust Freedom Plumbing for Affordable Water Heater Rep …
Freedom Plumbing is the trusted choice in Morristown, NJ for affordable water heater repairs and installations, keeping homes comfortable and reliable year-round.
Morristown, NJ - For many households, hot water is essential to daily life, from morning showers to evening chores. When water heaters fail or show signs of wear, the disruption can be significant. In Morristown, residents are increasingly turning to professional plumbing services to ensure their systems are running…
What to Do During a Plumbing Emergency: Joe Castro Plumbing Provides Crucial Tip …
Joe Castro Plumbing shares essential tips for Oak Ridge North residents on handling plumbing emergencies safely until professional help arrives.
Oak Ridge North, TX - Plumbing emergencies can happen without warning, and when they do, fast action is essential to minimize damage and restore safety. From burst pipes to overflowing toilets, these unexpected situations can disrupt daily life and cause costly repairs if not handled promptly. Local residents are being reminded…
More Releases for Biliary
Global Metal Pancreatic Biliary Stent Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Metal Pancreatic Biliary Stent market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The metal pancreatic biliary stent market is witnessing consistent growth due to the rising prevalence of…
Major Market Share Shift in Biliary Catheters Industry: Advancements In Biliary …
What Is the Forecasted Market Size and Growth Rate for the Biliary Catheters Market?
The market size for biliary catheters has experienced robust growth in recent years. There is an expected growth from $3.42 billion in 2024 to $3.75 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 9.7%. Factors like increased occurrences of biliary tract ailments, the popularity of minimally invasive procedures, a growing aging population, more…
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market
Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics
The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031.
Primary Biliary Cholangitis (PBC), formerly known as…
Biliary Stents Market - Unleashing Flow: Empowering Biliary Health with Innovati …
Newark, New Castle, USA - new report, titled Biliary Stents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biliary Stents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biliary Stents market. The report offers an overview of the market, which…
High Prevalence of Biliary Diseases Across the Globe is Driving the Biliary Sten …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
Rise in Surgical Procedures of Biliary Diseases is Expected to Boost the Biliary …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
